GLP-1 Receptor Agonist | Advanced Weight Loss & Glycaemic Research | For Research Use Only

Semaglutide is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist, widely studied for its role in appetite regulation, weight loss, and blood glucose control. It mimics the effects of endogenous GLP-1, stimulating insulin secretion, suppressing glucagon, and slowing gastric emptying — leading to reduced appetite and improved glycaemic outcomes.

Semaglutide has been the subject of extensive research in obesity, type 2 diabetes, and metabolic syndrome, demonstrating significant reductions in body weight and HbA1c levels in clinical and preclinical models.

🔍 Key Features

• Promotes Sustained Weight Loss & Appetite Suppression

• Improves Insulin Sensitivity & Glucose Tolerance

• Delays Gastric Emptying for Enhanced Satiety

• Research Applications in Obesity, T2DM, PCOS & NAFLD

• Once-Weekly Dosing with Extended Half-Life

⚙️ Compound Details

• Compound Name: Semaglutide

• CAS Number: 910463-68-2

• Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉

• Molecular Weight: ~4113.58 g/mol

• Purity: ≥ 98% (HPLC Verified)

• Form: Lyophilised white/off-white powder

• Unit Size: 20mg per vial

🧊 Storage & Handling

• Storage (lyophilised): Store at –20°C in a dry, dark environment

• Reconstitution: Use sterile bacteriostatic water

• Post-Reconstitution: Store at 2–8°C and use within 10 days

• Avoid: Repeated freeze-thaw cycles and light exposure

⚠️ For Research Use Only

Semaglutide – 20mg is provided exclusively for scientific research and investigational use. It is not for human use, therapeutic application, or diagnostic purposes.